435

Compound name
Osimertinib
Alt Name
AZD-9291
AZD9291
Mereletinib
Compound Image
Osimertinib.png
SMILES
CN1C=C(C2=CC=CC=C21)C3=NC(=NC=C3)NC4=C(C=C(C(=C4)NC(=O)C=C)N(C)CCN(C)C)OC
MW
499.60
Brutto
C28H33N7O2
InChI
InChI=1S/C28H33N7O2/c1-7-27(36)30-22-16-23(26(37-6)17-25(22)34(4)15-14-33(2)3)32-28-29-13-12-21(31-28)20-18-35(5)24-11-9-8-10-19(20)24/h7-13,16-18H,1,14-15H2,2-6H3,(H,30,36)(H,29,31,32)
InChI Key
DUYJMQONPNNFPI-UHFFFAOYSA-N
Approval Jurisdiction
2015 FDA 2016 EMA
Approved for clinical use
T790M+Ve NSCLC
CAS
1421373-65-0
PubChem CID
71496458
Action
EGFR
Approved Drug List
1
Commercial Vendor
AstraZeneca